Chemiluminescent immunoassay kit for detecting mycoplasma pneumoniae IgM antibody
A technology for chemiluminescence immunity and mycoplasma pneumoniae, which is applied in the direction of chemiluminescence/bioluminescence, analysis by making materials undergo chemical reactions, and measurement devices, to achieve the effects of easy storage, small differences between product batches, and reliable diagnostic basis
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0021] Embodiment 1, kit preparation method of the present invention
[0022] 1, the test kit of the present invention comprises:
[0023] 1) Mycoplasma pneumoniae IgM positive control; 2) Mycoplasma pneumoniae IgM negative control; 3) Mycoplasma pneumoniae IgM calibrator; 4) Microwell plate coated with FITC monoclonal antibody; 5) FITC-labeled Mycoplasma pneumoniae antigen; 6) Anti-human IgM Enzyme label; 7) 20-fold concentrated washing solution; and 8) chemiluminescence substrate solution.
[0024] Wherein, the microwell plate is a microwell strip with 24, 48 or 96 holes; the anti-human IgM is goat anti-human IgM polyclonal antibody, rabbit anti-human IgM polyclonal antibody or mouse anti-human IgM monoclonal antibody; the enzyme horseradish peroxidase.
[0025] 2, the preparation method of No. I kit of the present invention:
[0026] The positive control was prepared with the positive serum of Mycoplasma pneumoniae IgM, the negative control was prepared with the serum of...
Embodiment 2
[0071] Embodiment 2. Comparative test of the luminescence substrate of the kit of the present invention and the commercially available chemiluminescence substrate solution
[0072] Control kit: the same as the kit in Example 1, the difference is that the chemiluminescence substrate is a commercially available conventional chemiluminescence substrate solution (purchased from Huzhou Yingchuang Biotechnology Co., Ltd.).
[0073] Step 1. The detection samples are 254 cases of respiratory infection samples and blood samples of healthy people in Example 1.
[0074] The detection operation steps are the same as those in Step 3 of Example 1. The results are shown in the table below.
[0075] Table 4. No. I kit chemiluminescent substrate of the present invention is compared with the chemiluminescent substrate sold in the market
[0076]
[0077] The data described in Table 4 shows that the positive coincidence rate of the No. I kit chemiluminescent substrate of the present inventi...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 